S.H.J. van den Elsen

E-mail:
s.h.j.van.den.elsen umcg.nl

Research

Publications
  1. Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients

    van den Elsen, S. H. J., Sturkenboom, M. G. G., Akkerman, O. W., Manika, K., Kioumis, I. P., van der Werf, T. S., Johnson, J. L., Peloquin, C., Touw, D. J. & Alffenaar, J-W. C., Jul-2019, In : Antimicrobial Agents and Chemotherapy. 63, 7, 13 p., ARTN e00384-19.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs

    Kuhlin, J., Sturkenboom, M. G. G., Ghimire, S., Margineanu, I., Elsen, S. H. J. V. D., Simbar, N., Akkerman, O. W., Jongedijk, E. M., Koster, R. A., Bruchfeld, J., Touw, D. J. & Alffenaar, J-W. C., Sep-2019, In : Clinical Mass Spectrometry. 14, Part A, p. 34-45 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients

    van den Elsen, S. H. J., Sturkenboom, M. G. G., van 't Boveneind-Vrubleuskaya, N., Skrahina, A., van der Werf, T. S., Heysell, S. K., Mpagama, S., Migliori, G. B., Peloquin, C. A., Touw, D. J. & Alffenaar, J-W. C., Dec-2018, In : Antimicrobial Agents and Chemotherapy. 62, 12, 10 p., ARTN e01092-18.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (8) »

ID: 34985825